Sam L. Penza MD

Physician

460 W 10th Ave1st FloorColumbus, OH 43210
Phone+1 614-293-3316
Fax+1 614-293-6050

Dr. Penza is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Penza's full profile Already have an account?

Education & Training

Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1992 - 1995
Ohio State University HospitalResidency, Internal Medicine, 1989 - 1992
Ohio State University College of MedicineClass of 1989

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OH State Medical License 1991 - 2028
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 2012 Feb 09
COMPLETED
PHASE1, PHASE2

Publications & Presentations

PubMed

1 citations
Phase I Trial of Venetoclax and BEAM Followed by Autologous Stem Cell Transplant for High-Risk Non-Hodgkin Lymphoma.
Joseph E Maakaron, Qiuhong Zhao, Jayalakshmi P Balakrishna, Marcin Puto, Sam Penza
Transplantation and Cellular Therapy. 2026-07-01
Outcomes of Tocilizumab for Cytokine Release Syndrome after Post-Transplant Cyclophosphamide.
Tuan L Phan, Roberta Azbell, Hannah Choe, Nathan Denlinger, Marcos de Lima
Transplantation and Cellular Therapy. 2026-06-24
1 citations
Combination ruxolitinib, belumosudil, and axatilimab yields clinically significant symptomatic improvements in treatment-refractory chronic GVHD.
Jean Caputo, Ayush Peddireddi, Sarah Wall, Sumithira Vasu, Sam L Penza
Bone Marrow Transplantation. 2026-01-01

Abstracts/Posters

Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgki...
Sam Penza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Effect of Early Post Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
Sam Penza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019